Aged-looking skin and encorafenib: an adverse event of BRAF inhibitors

Melanoma Res. 2018 Apr;28(2):160-162. doi: 10.1097/CMR.0000000000000422.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Carbamates / adverse effects*
  • Humans
  • Male
  • Melanoma / drug therapy
  • Middle Aged
  • Protein Kinase Inhibitors / adverse effects*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Skin / drug effects*
  • Skin / pathology
  • Skin Aging / drug effects*
  • Skin Neoplasms / drug therapy
  • Sulfonamides / adverse effects*

Substances

  • Carbamates
  • Protein Kinase Inhibitors
  • Sulfonamides
  • encorafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf